Reply to M. Horiguchi et al

J Clin Oncol. 2017 Oct 10;35(29):3373-3374. doi: 10.1200/JCO.2017.74.4292. Epub 2017 Aug 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Humans
  • Indazoles
  • Paclitaxel*
  • Pyrimidines
  • Sulfonamides
  • Urologic Neoplasms*

Substances

  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib
  • Paclitaxel